Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Papillomavirus Infections 1Lymphoma 1Head and Neck Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 1270Specimen Handling 870Carboplatin 831Magnetic Resonance Spectroscopy 808Cyclophosphamide 802Cisplatin 728Nivolumab 658Paclitaxel 631Radiotherapy 573Gemcitabine 572Biopsy 529Bevacizumab 475Dexamethasone 440fludarabine 407Docetaxel 378venetoclax 370Oxaliplatin 365Capecitabine 356Fluorouracil 354atezolizumab 341durvalumab 334Rituximab 332Doxorubicin 316Radiosurgery 309Pemetrexed 305Drug Therapy 302Ipilimumab 294Standard of Care 293Etoposide 285Radiation 279

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cytological Techniques × 1 year × Clear all
NCT06574087 2025-07-23

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

PCK Marine Hospital in Gdynia

Phase NA Recruiting
248 enrolled
Gastrointestinal

Anus Neoplasms, Papillomavirus Infections

NCT05010369 2025-06-26

DOLPHIN-VIVO

University of Exeter

Phase NA Terminated
14 enrolled
Head & NeckLymphoid

Head and Neck Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡